Clinical efficacy and safety of oral hypoglycemic drugs in the treatment of gestational diabetes mellitus

Minerva Med. 2022 Dec;113(6):1028-1029. doi: 10.23736/S0026-4806.21.07877-0. Epub 2021 Nov 26.
No abstract available

MeSH terms

  • Administration, Oral
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes, Gestational* / drug therapy
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Insulin
  • Pregnancy
  • Treatment Outcome

Substances

  • Hypoglycemic Agents
  • Insulin